Allogeneic hematopoietic stem cell transplantation (HSCT) recipients frequently develop
acute respiratory failure (ARF) with pulmonary infiltrates. Molecular-and biomarker-based …

Park M, Koh KN, Kim BE, Im HJ, Seo JJ. Clinical features of late onset non‐infectious
pulmonary complications following pediatric allogeneic hematopoietic stem cell …

Non-malignant late effects after hematopoietic stem cell transplantation (HSCT) are
heterogeneous in nature and intensity. The type and severity of the late complications …

Study objective To describe the pulmonary findings at autopsy of blood and bone marrow
transplant (BMT) recipients. Design Retrospective. Setting An academic medical center …

Rationale: Acute respiratory distress syndrome (ARDS) is a common complication after
hematopoietic stem cell transplantation (HCT) and is a major contributor to nonrelapse …

Despite significant advances in critical care and transplantation medicine, non-infectious
lung injury remains a major problem following allogeneic hematopoietic stem cell …

We evaluated the incidence, the risk factors, and the outcome of late-onset noninfectious
pulmonary complications (LONIPCs) among 50 patients who underwent allogeneic stem cell …

Pulmonary complications after hematopoietic cell transplantation (HCT) can lead to
significant morbidity and mortality. Limited evaluation of the true incidence of these …

Hematopoietic stem cell transplantation is used to treat hematologic disorders and as an
adjunct treatment for solid organ malignancies. After undergoing transplantation, patients …

Background Late-onset noninfectious pulmonary complications (LONIPCs), which occur
more than 3 months after allogeneic hematopoietic stem cell transplantation (HSCT), are …